- To analyze historical tension between efforts to maximize drug safety and effectiveness while speeding pharmaceutical innovation.
- To probe role of patient advocacy organizations in modern day drug development.
- To assess the adequacy of methods the FDA uses in an effort to demonstrate regulatory flexibility while adhering to law and statue.
04/06/2022 - 12:00pm to 1:30pm CDT
P117 and Zoom
Add to calendar:
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Participation
G. Caleb Alexander, MD, MS